Sun Pharmaceutical Industries Share Price Today - Live Blog for August 20, 2025

Climbing steadily, Sun Pharmaceutical Industries Ltd shares have ascended by 0.25%, reaching the current market price of ₹1,635.50. This ascent signifies increased investor sentiment. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

After a significant 0.21% gain, Sun Pharmaceutical Industries Ltd's shares are now valued at ₹1,636.55 in the current market. This upward movement is attracting attention from both retail and institutional investors.

The share price of Sun Pharmaceutical Industries Ltd soared by an impressive 0.34%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,633.25 per share.

Sun Pharmaceutical Industries Ltd's shares experienced a 0.05% uptick, and they are currently valued at ₹1,627.60, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.0327 and an ROE of 15.1334%.

The share price of Sun Pharmaceutical Industries Ltd recently experienced a positive upturn, resulting in a 0.01% increase. Presently, it is actively trading at ₹1,627.80.

Sun Pharmaceutical Industries Ltd witnessed a -0.01% decrease in its share price, and it is currently trading at ₹1,628.05. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 37.6200, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

The share price of Sun Pharmaceutical Industries Ltd recently experienced a positive upturn, resulting in a 0.12% increase. Presently, it is actively trading at ₹1,627.85.

Sun Pharmaceutical Industries Ltd share price surged by 0.12%. With its current market price standing at ₹1,627.85 per share, this stock is garnering increased attention from the investment community.

The share price of Sun Pharmaceutical Industries Ltd soared by an impressive 0.09%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,625.45 per share.

The share price of Sun Pharmaceutical Industries Ltd soared by an impressive 0.09%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,625.45 per share.

With a -0.02% decrease, Sun Pharmaceutical Industries Ltd's share price is now ₹1,625.00. Investors should examine the factors driving this decline. The stock's PE ratio is 37.6200, whereas the industry PE ratio stands at 34.8748.

In the financial arena, Sun Pharmaceutical Industries Ltd's stock price has increased by 0.06%, with its current market value per share resting at ₹1,626.85. This development highlights the stock's appeal to investors.

Following a noteworthy 0.06% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,626.85. When it comes to valuation, this stock has a PE ratio of 37.6200, with the industry PE ratio at 34.8748.

Sun Pharmaceutical Industries Ltd experienced a substantial 0.01% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,625.30, making it an appealing option for investors.

Sun Pharmaceutical Industries Ltd's stock price surged by 0.01%, reaching the current market value of ₹1,625.30 per share. This surge is a testament to the stock's recent performance.

Sun Pharmaceutical Industries Ltd shares saw a -0.08% decrease, reaching a current market price of ₹1,624.15. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 37.6200, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

The share price of Sun Pharmaceutical Industries Ltd soared by an impressive 0.13%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,625.85 per share.

After a notable 0.22% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,625.15. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.0327 and an ROE of 15.1334%.

Sun Pharmaceutical Industries Ltd's stock has risen by a substantial 0.10%, and as of now, it's trading at ₹1,622.00 per share. This upward trajectory is attracting keen interest from investors.

Sun Pharmaceutical Industries Ltd's shares experienced a 0.06% uptick, and they are currently valued at ₹1,620.30, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.0327 and an ROE of 15.1334%.

The stock of Sun Pharmaceutical Industries Ltd has experienced a -0.04% drop, and it's now trading at ₹1,618.30 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.10% decline, and it currently trades at ₹1,620.00 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Sun Pharmaceutical Industries Ltd witnessed a notable 0.02% surge in its share price and is presently trading at ₹1,621.55, captivating the attention of market participants.

The stock of Sun Pharmaceutical Industries Ltd is on the rise, registering an impressive 0.06% increase and currently trading at ₹1,620.50 per share. Investors are taking notice of this upward momentum.

Sun Pharmaceutical Industries Ltd's share price has dropped by -0.34%, a development that warrants careful analysis. Presently trading at ₹1,618.00, investors are assessing whether this presents an opportunity or a risk.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.17% drop, and it's now trading at ₹1,623.50 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.